Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CUPR declined for three days, in 104 of 109 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CUPR as a result. In 23 of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CUPR's RSI Indicator exited the oversold zone, 9 of 10 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 16 of 19 cases where CUPR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for CUPR just turned positive on September 30, 2026. Looking at past instances where CUPR's MACD turned positive, the stock continued to rise in 15 of 15 cases over the following month. The odds of a continued upward trend are 90%.
Following a +25.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where CUPR advanced for three days, in 52 of 58 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.454) is normal, around the industry mean (4.961). P/E Ratio (-1.024) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (104.167) is also within normal values, averaging (56.876).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. CUPR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CUPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
On October 22, 2026, the Stochastic Oscillator for NNNN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 20 instances where the indicator left the oversold zone. In 19 of the 20 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NNNN's RSI Indicator exited the oversold zone, 8 of 9 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
Following a +19.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where NNNN advanced for three days, in 91 of 93 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
NNNN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NNNN as a result. In 27 of 29 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for NNNN turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 11 similar instances when the indicator turned negative. In 11 of the 11 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NNNN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for NNNN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.865) is normal, around the industry mean (4.961). P/E Ratio (40.884) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (28.169) is also within normal values, averaging (56.876).
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. NNNN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNNN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
| CUPR | NNNN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 1 day ago 89% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 22 days ago 90% | 3 days ago 90% |
| Declines ODDS (%) | 7 days ago 90% | 1 day ago 90% |
| BollingerBands ODDS (%) | N/A | 1 day ago 90% |
| Aroon ODDS (%) | N/A | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CUPR’s FA Score shows that 1 FA rating(s) are green while NNNN’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CUPR’s TA Score shows that 6 TA indicator(s) are bullish while NNNN’s TA Score has 4 bullish TA indicator(s).
CUPR (@Pharmaceuticals: Other) experienced а +1.01% price change this week, while NNNN (@Pharmaceuticals: Other) price change was +4.20% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor tells us that CUPR and RGEN have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CUPR and RGEN's prices will move in lockstep.
| Ticker / NAME | Correlation To CUPR | 1D Price Change % | ||
|---|---|---|---|---|
| CUPR | 100% | -6.97% | ||
| RGEN - CUPR | 8% Poorly correlated | -0.72% | ||
| KMTS - CUPR | 7% Poorly correlated | +3.70% | ||
| BLCO - CUPR | 5% Poorly correlated | +1.46% | ||
| NNNN - CUPR | 4% Poorly correlated | -0.27% | ||
| AZTA - CUPR | 3% Poorly correlated | -2.04% | ||
More | ||||
A.I.dvisor tells us that NNNN and KRMD have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNNN and KRMD's prices will move in lockstep.
| Ticker / NAME | Correlation To NNNN | 1D Price Change % | ||
|---|---|---|---|---|
| NNNN | 100% | -0.27% | ||
| KRMD - NNNN | 10% Poorly correlated | -1.13% | ||
| NEPH - NNNN | 8% Poorly correlated | -1.95% | ||
| ZJYL - NNNN | 8% Poorly correlated | +1.05% | ||
| SOLV - NNNN | 8% Poorly correlated | +0.90% | ||
| FEMY - NNNN | 7% Poorly correlated | -5.45% | ||
More | ||||